1. Considered and approved and taken on records the Audited Financial Results along with the Statement of Assets and Liabilities and the Audit Report for the quarter and financial year ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Resgen Ltd approved the audited financial results for the half year and full year ended 31st March, 2025, with the statutory auditors (Jay Gupta & Associates) issuing an unmodified (clean) opinion. Total revenue from operations for FY25 jumped to ₹6,515.93 lakhs from ₹4,550.15 lakhs in FY24, a growth of roughly 43%. Profit after tax rose to ₹797.53 lakhs from ₹656.88 lakhs (~21% growth), lifting EPS to ₹3.80 from ₹3.13. The company trimmed both long-term borrowings (₹453.05 → ₹267.58 lakhs) and short-term borrowings (₹413.31 → ₹197.78 lakhs), while cash and cash equivalents improved sharply from ₹0.68 lakhs to ₹175.32 lakhs. Net cash from operating activities was healthy at ₹748.62 lakhs for the year.
A clean audit, strong ~43% revenue growth, lower debt, and a healthier cash balance are positive signals for shareholders, supporting a constructive near-term view on the stock. Investors should however note that PAT growth (~21%) lagged the headline revenue surge, indicating margin compression.